Max Bayer – Page 8 – Endpoints News

about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

CDC advisors decline to recommend RSV shots to younger at-risk adults, affirming prior guidance

7 months ago

Icon's quarterly earnings hit by biotech and pharma pullback

7 months ago

Adults 50 and up should get pneumococcal vaccine, CDC advisors say, in boost to Pfizer and Merck

7 months ago

Pfizer wins approval to expand RSV vaccine to adults at higher infection risk

7 months ago

Starboard's Kenvue complaints are much different than those aimed at Pfizer

7 months ago

Updated: Pfizer's activist says board must 'hold management accountable' for R&D shortcomings

7 months ago

Starboard takes activist stake in J&J consumer spinout Kenvue

7 months ago

Vertex shares full pivotal non-opioid pain data, showing better safety than placebo

7 months ago

Lykos is optimistic about MDMA treatment after meeting with FDA

7 months ago

Pfizer’s RSV vaccine has 90% efficacy against severe respiratory disease

7 months ago

Bavarian Nordic's mpox vaccine was safe and spurred promising immune response in children

7 months ago

Facing a critical week, Pfizer confronts an unsparing foe in Starboard

7 months ago

J&J’s medtech slump continues, improvements not expected until 2025

7 months ago

J&J trims pipeline, including two mid-stage neuroscience studies

7 months ago

Sanofi lands on private equity firm CD&R as potential buyer of consumer health unit

7 months ago

Sanofi discontinues Denali-partnered MS trial after Phase 2 failure

7 months ago

Exclusive: How an accidental email tipped Pfizer off to an activist investor’s plan

7 months ago

Starboard launches first salvo in Pfizer fight, alleging ex-CEO, CFO were pressured to flip

7 months ago

Former Pfizer CEO and CFO flip on activist and say they now support company

7 months ago

Covering obesity drugs could cost Medicare $35B by 2034, CBO says

7 months ago

Pfizer's former top executives pitched changes to board as part of activist's plan

7 months ago

BARDA doles out $72M to Sanofi, GSK and CSL for bird flu vaccine supply

7 months ago

J&J discontinues mid-stage dengue study, citing deprioritization of communicable disease work

7 months ago

Exclusive: Relay Therapeutics cuts another 10% of company, citing continued streamlining efforts

8 months ago

First page Previous page 5 6 789 10 11 Next page Last page